Finding the new injectable in the United Kingdom can be difficult. Currently, Retatrutide isn't broadly accessible through the public healthcare system. Select physicians are beginning to provide it, but distribution remains limited . Patients seeking to secure this prescription treatment should anticipate assessment charges and possible delays . R